Medical Experts Call for Genetic Screening in Glaucoma Care

Medical professionals are increasingly advocating for the integration of genetic screening into routine glaucoma care. Experts emphasize that identifying specific genetic markers allows for earlier intervention, potentially preventing significant vision loss in high-risk patients. Recent discussions at the GENE-SIGHT 2026 conference highlighted that genetic insights provide a more precise map for disease progression, marking a shift toward personalized medicine for eye health in India.

Glaucoma is often hereditary, and traditional screening methods may miss early signs until irreversible damage occurs. By leveraging genetic information, doctors can now predict the onset and trajectory of the disease more accurately than with conventional pressure-based tests alone. This approach moves the focus from reacting to established symptoms to predicting and preventing progression, which is particularly relevant in the Indian context where early diagnostic infrastructure remains a primary challenge.

The adoption of genetic testing is expected to become an integral part of ophthalmic care as diagnostic costs decrease and reliability improves. Medical authorities stress that a standardized protocol for genetic screening could save thousands from preventable blindness. As this technology gains traction, the healthcare sector is preparing for a transition towards data-driven monitoring strategies that tailor treatment intensity to an individual's unique genetic profile and risk factors.